2,696
Views
6
CrossRef citations to date
0
Altmetric
Pages 278-282 | Received 11 Mar 2020, Accepted 11 May 2020, Published online: 23 Jun 2020

References

  • World Health Organization. Acute intussusception in infants and children. Incidence, clinical presentation and management: A global perspective. Geneva, Switzerland: World health organization. Document who/v & b/02.19.1–98; 2019. Accessed April. Available from https://vaccine-safety-training.org/tl_files/vs/pdf/acute-intussusception-infants-children.pdf.
  • Bines JE, Kohl KS, Forster J, Zanardi LR, Davis RL, Hansen J, Murphy TM, Music S, Niu M, Varricchio F, et al. Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine. 2004;22;(5-6(5–6):569–74. doi:10.1016/j.vaccine.2003.09.016.
  • Clark AD, Hasso-Agopsowicz M, Kraus MW, Stockdale LK, Sanderson CFB, Parashar UD, Tate JE. Update on the global epidemiology of intussusception: A systematic review of incidence rates, age distributions and case-fatality ratios among children aged <5 years, before the introduction of rotavirus vaccination. Int J Epidemiol. 2019. doi:10.1093/ije/dyz028.
  • Marsicovetere P, Ivatury SJ, White B, Holubar SD. Intestinal intussusception: etiology, diagnosis, and treatment. Clin Colon Rectal Surg. 2017;30(1):30–39. doi:10.1055/s-0036-1593429.
  • Tate JE, Burton AH, C B-P, Parashar UD. World health organization-coordinated global rotavirus surveillance N. Global, regional, and national estimates of rotavirus mortality in children <5 years of age, 2000-2013. Clin Infect Dis. 2016;62(Suppl 2):S96–S105. doi:10.1093/cid/civ1013.
  • Patel MM, Lopez-Collada VR, Bulhoes MM, De Oliveira LH, Bautista Marquez A, Flannery B, Esparza-Aguilar M, Montenegro Renoiner EI, Luna-Cruz ME, Sato HK, et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med. 2011;364(24):2283–92. doi:10.1056/NEJMoa1012952.
  • Molto Y, Cortes JE, De Oliveira LH, Mike A, Solis I, Suman O, Coronado L, Patel MM, Parashar UD, Cortese MM. Reduction of diarrhea-associated hospitalizations among children aged < 5 years in panama following the introduction of rotavirus vaccine. Pediatr Infect Dis J. 2011;30(1 Suppl):S16–20. doi:10.1097/INF.0b013e3181fefc68.
  • Poelaert D, Pereira P, Gardner R, Standaert B, Benninghoff B. A review of recommendations for rotavirus vaccination in europe: arguments for change. Vaccine. 2018;36(17):2243–53. doi:10.1016/j.vaccine.2018.02.080.
  • Kassim P, Eslick GD. Risk of intussusception following rotavirus vaccination: an evidence based meta-analysis of cohort and case-control studies. Vaccine. 2017;35(33):4276–86. doi:10.1016/j.vaccine.2017.05.064.
  • Rosillon D, Buyse H, Friedland LR, Ng SP, Velazquez FR, Breuer T. Risk of intussusception after rotavirus vaccination: meta-analysis of postlicensure studies. Pediatr Infect Dis J. 2015;34(7):763–68. doi:10.1097/INF.0000000000000715.
  • Dong R, Yang YF, Chen G, Shen Z, Zheng S. Risk of intussusception after rotavirus vaccination: A meta-analysis. Int J Clin Exp Med. 2016;9:1306–13.
  • Centers for Disease C, Prevention. Withdrawal of rotavirus vaccine recommendation. MMWR Morb Mortal Wkly Rep. 1999;48(43):1007.
  • Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354(1):11–22. doi:10.1056/NEJMoa052434.
  • Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, et al. Safety and efficacy of a pentavalent human-bovine (wc3) reassortant rotavirus vaccine. N Engl J Med. 2006;354(1):23–33. doi:10.1056/NEJMoa052664.
  • Global advisory committee on vaccine safety. 11-12 december 2013. Releve Epidemiologique Hebdomadaire. 2014;89(7):53–60.
  • Koch J, Harder T, von Kries R, Wichmann O. Risk of intussusception after rotavirus vaccination. Dtsch Arztebl Int. 2017;114(15):255–62. doi:10.3238/arztebl.2017.0255.
  • Tate JE, Mwenda JM, Armah G, Jani B, Omore R, Ademe A, Mujuru H, Mpabalwani E, Ngwira B, Cortese MM, et al. Evaluation of intussusception after monovalent rotavirus vaccination in Africa. N Engl J Med. 2018;378(16):1521–28. doi:10.1056/NEJMoa1713909.
  • Valcarcel Salamanca B, Hagerup-Jenssen ME, Flem E. Uptake and timeliness of rotavirus vaccination in Norway: the first year post-introduction. Vaccine. 2016;34(39):4684–89. doi:10.1016/j.vaccine.2016.08.017.
  • Global Advisory Committee on Vaccine Safety. Weekly epidemiological record. World Health Organization;2020. 2020 January 24.
  • Buttery JP, Danchin MH, Lee KJ, Carlin JB, McIntyre PB, Elliott EJ, Booy R, Bines JE, Group PAS Intussusception following rotavirus vaccine administration: post-marketing surveillance in the national immunization program in australia. Vaccine. 2011;29(16):3061–66. doi:10.1016/j.vaccine.2011.01.088.
  • Tate JE, Yen C, Steiner CA, Cortese MM, Parashar UD. Intussusception rates before and after the introduction of rotavirus vaccine. Pediatrics. 2016:138(3). doi:10.1542/peds.2016-1082.
  • Simonsen L, Morens D, Elixhauser A, Gerber M, Van Raden M, Blackwelder W. Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception. Lancet. 2001;358(9289):1224–29. doi:10.1016/S0140-6736(01)06346-2.
  • Yen C, Tate JE, Steiner CA, Cortese MM, Patel MM, Parashar UD. Trends in intussusception hospitalizations among us infants before and after implementation of the rotavirus vaccination program, 2000-2009. J Infect Dis. 2012;206(1):41–48. doi:10.1093/infdis/jis314.
  • Hawken S, Ducharme R, Rosella LC, Benchimol EI, Langley JM, Wilson K, Crowcroft NS, Halperin SA, Desai S, Naus M, et al. Assessing the risk of intussusception and rotavirus vaccine safety in Canada. Hum Vaccin Immunother. 2017;13(3):703–10. doi:10.1080/21645515.2016.1240846.
  • Yen C, Shih SM, Tate JE, Wu FT, Huang YC, Parashar UD, Hsiung CA. Intussusception-related hospitalizations among infants before and after private market licensure of rotavirus vaccines in Taiwan, 2001-2013. Pediatr Infect Dis J. 2017;36(10):e252–e257. doi:10.1097/INF.0000000000001644.
  • Cho HK, Hwang S, Nam H Trends in the incidence of intussusception before and after the private market licensure of rotavirus vaccine in korea: A nationwide cross-sectional study. Poster presented on the 36th annual meeting of the european society for paediatric infectious diseases; may 28-june 2; 2018; malmö (sweden).
  • Belongia EA, Irving SA, Shui IM, Kulldorff M, Lewis E, Yin R, Lieu TA, Weintraub E, Yih WK, Li R, et al. Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine. Pediatr Infect Dis J. 2010;29(1):1–5. doi:10.1097/INF.0b013e3181af8605.
  • Shui IM, Baggs J, Patel M, Parashar UD, Rett M, Belongia EA, Hambidge SJ, Glanz JM, Klein NP, Weintraub E. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants. Jama. 2012;307(6):598–604. doi:10.1001/jama.2012.97.
  • Burke RM, Tate JE, Dahl RM, Aliabadi N, Parashar UD. Does rotavirus vaccination affect longer-term intussusception risk in US infants? J Pediatric Infect Dis Soc. 2019. doi:10.1093/jpids/piz035.
  • Willame C, Cheuvart B, Aris E, Vetter V, Cohet C. Association between rotavirus gastroenteritis and intussusception: suggested evidence from a retrospective study in claims databases in the United States. Submitted for publication. Hum Vaccin Immunother. 2020;17(1).
  • Restivo V, Costantino C, Giorgianni G, Cuccia M, Tramuto F, Corsello G, Casuccio A, Vitale F. Case-control study on intestinal intussusception: implications for anti-rotavirus vaccination. Expert Rev Vaccines. 2018;17(12):1135–41. doi:10.1080/14760584.2018.1546122.
  • Mansour AM, El Koutby M, El Barbary MM, Mohamed W, Shehata S, El Mohammady H, Mostafa M, Riddle MS, Sebeny PJ, Young SY, et al. Enteric viral infections as potential risk factors for intussusception. J Infect Dev Ctries. 2013;7(1):28–35. doi:10.3855/jidc.2321.
  • Minney-Smith CA, Levy A, Hodge M, Jacoby P, Williams SH, Carcione D, Roczo-Farkas S, Kirkwood CD, Smith DW. Intussusception is associated with the detection of adenovirus c, enterovirus b and rotavirus in a rotavirus vaccinated population. J Clin Virol. 2014;61(4):579–84. doi:10.1016/j.jcv.2014.10.018.
  • Robinson CG, Hernanz-Schulman M, Zhu Y, Griffin MR, Gruber W, Edwards KM. Evaluation of anatomic changes in young children with natural rotavirus infection: is intussusception biologically plausible? J Infect Dis. 2004;189(8):1382–87. doi:10.1086/382655.
  • Tate JE, Simonsen L, Viboud C, Steiner C, Patel MM, Curns AT, Parashar UD. Trends in intussusception hospitalizations among us infants, 1993-2004: implications for monitoring the safety of the new rotavirus vaccination program. Pediatrics. 2008;121(5):e1125–1132 doi:10.1542/peds.2007-1590.
  • Tai JH, Curns AT, Parashar UD, Bresee JS, Glass RI. Rotavirus vaccination and intussusception: can we decrease temporally associated background cases of intussusception by restricting the vaccination schedule? Pediatrics. 2006;118(2):e258–264. doi:10.1542/peds.2005-2874.
  • Standaert B, Alwan A, Strens D, Raes M, Postma MJ. Improvement in hospital quality of care (qoc) after the introduction of rotavirus vaccination: an evaluation study in Belgium. Hum Vaccin Immunother. 2015;11(9):2266–73. doi:10.1080/21645515.2015.1029212.